Cross-Market Validation of AI-Augmented Commercial Leadership: A Comparative Research Framework for Institutional Context, Field-Force Adaptation, and Transferability Across Pharmaceutical Markets

Abstract

Artificial intelligence models for commercial leadership are often developed in one organizational or national setting and then treated as transferable. This conceptual and methodological preprint develops a cross-market validation framework for AI-augmented pharmaceutical commercial leadership. It distinguishes an invariant core of constructs, mechanisms, and outcome definitions from a configurable local layer involving regulation, customer access, data availability, managerial discretion, workforce expectations, and commercial operating models. Azerbaijan, Kazakhstan, and the United States are presented as prospective comparative field settings rather than as sources of completed empirical findings. The proposed program combines qualitative construct elicitation, translation and cognitive interviewing, pilot testing, measurement invariance, longitudinal field evaluation, and a formal transfer audit. The paper provides a framework for deciding whether an AI-augmented commercial leadership model should be replicated, adapted, restricted, or rejected across different pharmaceutical markets.